Trials / Completed
CompletedNCT04403334
Postoperative Safety Outcomes of Intraoperative Intracameral Preservative-Free Moxifloxacin Versus Levofloxacin
Postoperative Safety Outcomes in Patients Undergoing Routine Phacoemulsification Cataract Surgery With Intraoperative Intracameral Injection of Preservative-Free Moxifloxacin Versus Levofloxacin
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 114 (actual)
- Sponsor
- Peregrine Eye and Laser Institute · Academic / Other
- Sex
- All
- Age
- 21 Years – 100 Years
- Healthy volunteers
- Accepted
Summary
Comparative safety study of intracameral levofloxacin versus moxifloxacin for postoperative infection prophylaxis
Detailed description
Randomized clinical trial comparing corneal and retinal changes after intracameral levofloxacin or moxifloxacin administered at the end of surgery among eyes undergoing uncomplicated phacoemulsification.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levofloxacin Ophthalmic | 0.1 ml of unpreserved 0.5% levofloxacin |
| DRUG | Moxifloxacin Ophthalmic | 0.1 ml of unpreserved 0.5% moxifloxacin |
Timeline
- Start date
- 2018-01-02
- Primary completion
- 2018-04-28
- Completion
- 2018-04-28
- First posted
- 2020-05-27
- Last updated
- 2020-05-27
Locations
1 site across 1 country: Philippines
Source: ClinicalTrials.gov record NCT04403334. Inclusion in this directory is not an endorsement.